Biodentine is a new tricalcium silicate-based restorative cement that can be used as a dentin substitute with superior physical and biological properties compared to MTA. It sets faster than MTA due to the addition of calcium chloride as an accelerator. Upon setting, Biodentine releases calcium ions that stimulate reparative dentin formation and pulp healing. Studies show Biodentine forms a stronger bond to dentin and achieves higher mechanical strengths than MTA, making it suitable for various restorative, endodontic and pulp capping procedures.
major advantages and unique features as well as its ability to overcome the disadvantages of other materials, biodentine has great potential to revolutionize the different aspects of managing both primary and permanent in endodontics as well as operative dentistry.
major advantages and unique features as well as its ability to overcome the disadvantages of other materials, biodentine has great potential to revolutionize the different aspects of managing both primary and permanent in endodontics as well as operative dentistry.
An inlay may cap none, or may cap all but one cusp.
Sturdevant’s 4th ed. page579
Inlays may be used as single-tooth restorations for proximo-occlusal or gingival lesions with minimal to moderate extensions
Shillingburg page 1
An inlay may be defined as a restoration which has been constructed out of mouth from gold, porcelain, or other material & then cemented into the prepared cavity of a tooth.
William McGehee pg410
this presentation has all the techniques in impression making in the fabrication of an RPD.
The presentation is available on request. Mail me at apurvathampi@gmail.com
Biodentine™ with Active Biosilicate Technology™ was announced by dental materials manufacturer
Septodont in September of 2010, and made available in January of 2011. According to the research and
development department of said manufacturer, “a new class of dental material which could conciliate high
mechanical properties with excellent biocompatibility, as well as bioactive behaviour” (Septodont
Biodentine™ scientific file, 2010) had been produced. According to the manufacturer, the material can be
used as a “dentine replacement material whenever original dentine is damaged
An inlay may cap none, or may cap all but one cusp.
Sturdevant’s 4th ed. page579
Inlays may be used as single-tooth restorations for proximo-occlusal or gingival lesions with minimal to moderate extensions
Shillingburg page 1
An inlay may be defined as a restoration which has been constructed out of mouth from gold, porcelain, or other material & then cemented into the prepared cavity of a tooth.
William McGehee pg410
this presentation has all the techniques in impression making in the fabrication of an RPD.
The presentation is available on request. Mail me at apurvathampi@gmail.com
Biodentine™ with Active Biosilicate Technology™ was announced by dental materials manufacturer
Septodont in September of 2010, and made available in January of 2011. According to the research and
development department of said manufacturer, “a new class of dental material which could conciliate high
mechanical properties with excellent biocompatibility, as well as bioactive behaviour” (Septodont
Biodentine™ scientific file, 2010) had been produced. According to the manufacturer, the material can be
used as a “dentine replacement material whenever original dentine is damaged
Management of Open Apex in Permanent Teeth with BiodentineAbu-Hussein Muhamad
Biodentine is new calcium silicate based cement that exhibits physical and chemical properties similar to those described for certain Portland cement derivatives. This article demonstrates the use of the newer material, Biodentine as an apical matrix barrier in root end apexification procedure. This case reports present apexification and successful healing with the use of Biodentine as an apical barrier matrix.
Bioactive materials are revolutionizing oral health care and the quest for newer materials is never ending especially in the field of dental science. Research on biomaterials intensely involves interdisciplinary contributions from several major areas and requires extensive knowledge of medical science, materials science, biochemistry, biomedical engineering and clinical science. They are broadly used in the field of conservative dentistry and periodontics for regeneration, repair and reconstruction by acting directly on the vital tissue inducing its healing and repair through induction of various growth factors and different cells. This article reviews on the properties and clinical application of newer bioactive materials in endodontics, with a primary focus on the biocompatibility and tissue response to these materials.
Indian Dental Academy: will be one of the most relevant and exciting
training center with best faculty and flexible training programs
for dental professionals who wish to advance in their dental
practice,Offers certified courses in Dental
implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic
Dentistry, Periodontics and General Dentistry.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
2. Loss of dentine is perhaps one of the major losses which restrict the integrity of the
tooth structure to a significant extent. Whether be in the coronal or radicular
portion, dentine loss must be substituted with an artificial material, which can
restore the physiological integrity of the tooth structure.
Also, the preservation and protection of the dental pulp with specific emphasis on
regeneration is the new treatment strategy in the fields of dentistry.
For many decades since 1928, calcium hydroxide (Dycal) has been standard
material for maintaining the vitality of pulp since it is capable of stimulating
tertiary dentine formation. However it has some drawbacks like poor bonding to
dentine, material resorption.
3. After that, hydraulic calcium silicate cements were available which showed a
bioactive dynamic interaction with dentine and pulp tissue interface.
Recently, various calcium silicate based products have been launched to the
market, one of these is Biodentine; which became commercially available in
2009 by (Gilles and Olivier in corporation with Septodont's, France).
Biodentine is a new tricalcium silicate (Ca3SiO5) based inorganic restorative
commercial cement and advertised as ‘bioactive dentine substitute’.
This material is claimed to possess better physical and biological properties
compared to other tricalcium silicate cements such as mineral trioxide
aggregate (MTA) and Bioaggregate.
4. A. Powder: packaged in capsule (0.7 g).
1. Tricalcium Silicate: it’s the main component.
2. Diclacium Silicate: it’s the second main component.
3. Calcium Carbonate: as filler.
4. Zirconium Oxide: responsible for radiopacity.
5. Iron Oxide: responsible for shade.
B. Liquid: packaged in pipette (0.18 ml).
1. Calcium Chloride: as accelerator.
2. Hydrosoluble polymer: (water reducing agent) maintain the balance
between low water content and consistency of mixture.
3. Water.
5.
6. The calcium silicate has the ability to interact with water leading to the setting
and hardening of the cement as following:
CSH gel is considered as the matrix of the cement, and the crystals of
CaCO3 (rough and irregular) are filling the spaces between gel of cement.
Calcite (CaCO3) has two distinct functions: as an active agent (implicated
in the process of hydration) and as filler (improves the mechanical
properties of the cement).
7. The final result of hydration reaction includes: unreacted particles of cement
(slowing down the effect of further reaction), CSH gel, Ca (OH)2.
8. The powder is mixed with liquid in capsule in triturator for 30 seconds.
The setting time of Biodentine is between (9-12 minutes) due to the presence of:
Calcium Chloride as accelerator.
Hydrosoluble polymer (water reducing agent).
This represents a great improvement compared to the other calcium silicate
dental materials (MTA), which set in more than 2 hours.
9. There are two hypothesis or two processes may well combine, eventually in
contributing to the adhesion of the Biodentine cement to dental surface:
Physical process of crystal growth within dentine tubules leading to a
micromechanical anchor (tag) which ensuring long lasting seal.
Ion exchanges between the cement and dental tissues Biodentine - adhesive
systems.
Adhesion of Biodentine is higher than Dycal and MTA.
11. The use of hydrosoluble polymer in Biodentine composition which
reduce the amount of water which has positive influence on
density of Biodentine.
The lower porosity of Biodentine leads to higher mechanical
strength. Biodentine exhibits lower porosity than Dycal and MTA.
13. There is a sharp increase in the compressive strength reaching more than 100
MPa in the first hour.
Then compressive strength continues to improve to reach more than 200 MPa
at 24h which is more than most glass ionomer value.
A specific feature of Biodentine is its capacity to continue improving with time
over several days until reaching 300 MPa after one month. This value becomes
quite stable and is in the range of the compressive strength of natural dentine
(297 MPa).
14. There is an increase in the micro hardness of Biodentine with
time.
After 1 month, hardness of Biodentine reach in the same range as
natural dentine.
15. The deposition of apatite like calcium phosphate crystals on the surface.
This improves interface between Biodentine and adjacent phosphate-
rich hard tissue substance. This leads to increase resistance to acid
erosion and microleakage.
Biodentine appeared resistance to
erosion and microleakage more
than MTA, Dycal and GIC.
16. Biodentine is associated with its ability to release hydroxyl and calcium ions.
The release of free calcium ion in Biodentine is higher than MTA and Dycal.
The high Ca release of Biodentine can be correlated with the presence of a
calcium silicate component and calcium chloride and calcium carbonate.
In addition, the fast hydration reaction of tricalcium silicate can be
correlated with high calcium release at early endpoints.
17.
18. Biodentine exhibits significant amount of antibacterial activity.
Calcium hydroxide ions released from cement during setting phase
of Biodentine increases pH to 12 (alkaliniztion of medium) which
inhibits the growth of microorganisms and can disinfect the
dentine.
19. Biodentine is not as stable as a composite material, so that
Biodentine is not suitable as permanent enamel replacement.
However, in comparison to other Portland cement- based
products, Biodentine is stable enough to find use as a temporary
filling even in the chewing load bearing region.
20. Biodentine induces mineralization after its application. Mineralization
occurs in the form of osteodentine that form reparative dentine.
The ability to release calcium is a key factor for successful pulp
capping therapies because of the action of calcium on differentiation,
proliferation and mineralization of pulp cells (osteoblasts,
cementoblasts, and odontoblasts).
21. Ca and hydroxide ions enhances the activity of:
(((Osteopontin, Alkaline Phosphatase, Pyrophosphatase, Bone
Morphogenetic Protein-2(BMP-2) which belongs to the TGF-β)))
which helps to maintain dentine mineralization and the formation of
dentine bridge.
TGF-β1 is responsible for early mineralization of reparative dentine
that secrete from the pulp cells .
22. For crown and root indications.
Helps in reminerlization of dentine.
Preserves pulp vitality and promotes pulp healing.
Replaces natural dentine with the same mechanical properties.
Better handling and manipulation.
Reduced setting time.
23.
24. Due to its dentine like mechanical properties, Biodentine can be used as
permanent dentine substitute (base) under a composite or amalgam especially
in deep carious teeth.
MTA cant be used as a base under restoration because it contains on aluminates
which increase the brittleness of it, while Biodentine not contains on aluminates
that results smart ideal base under restoration.
25. It includes direct and indirect pulp capping.
Biodentine can be used as pulp capping agent since it causes early
mineralization by release of TGF-β1 from pulpal cells to encourage pulp healing
and by odontoblast stimulation for dentine bridge formation to protect the pulp.
Histologically, Biodentine were showed complete dentinal bridge formation
(well localized pattern) and absence of inflammatory pulpal response in
contrast to Dycal that associated with tissue necrosis and inflammation during
initial period of placement.
28. Pulpotomy is another vital pulp treatment method in which Biodentine is
advocated to be used. This method is widely used in pediatric dentistry and
involves the amputation of pulp chamber and the placement of a material for
the preservation of the radicular pulp tissue’s vitality. This methodology is
specifically useful and preferred when the coronal pulp tissue is inflamed and a
direct pulp capping is not a suitable option.
The rate of success of vital pulpotomy with Biodentine is higher than MTA and
Pulpotec.
29.
30. Due to their good adhesion to dentine surface and fast setting time,
Biodentine is the ideal material for repairing of perforation
(bifurcation, root) after endodontic treatment. Also Biodentine can
be used in repair of root resorption, in apexification.
31. Many materials (amalgam, ZOE, GIC, MTA) were used as root
end filling, which have many problems.
Biodentine can be used as root end filling after apicectomy because
it has better consistency, better handling, safety and faster setting
time.
32.
33. • Arora V, Nikhil V, Sharma N, Arora P. Bioactive dentine replacement. JDMS. 2013; 12(4): 51-57.
• Bakopoulou A, About I. Biodentine™, a promising bioactive material for the preservation of pulp
vitality in restorative dentistry. Septodont case studies collection. 2013; 5: 4-10.
• Cutts G. Vital pulp therapy / Pulp capping with Biodentine™. Septodont case studies collection.
2013; 5: 15-18.
• Gandolfi MG, Siboni F, Botero T, Bossu M, Riccitiello F, Prati C. Calcium silicate and calcium
hydroxide materials for pulp capping: biointeractivity, porosity, solubility and bioactivity of current
formulations. J Appl Biomater Funct Mater. 2014; 1-18.
• Gandolfi MG, Siboni F, Polimeni A, Bossu M, Riccitiello F, Rengo S, Prati C. In vitro screening of
the apatite-forming ability, biointeractivity and physical properties of a tricalcium silicate material
for Endodontics and Restorative Dentistry. Dent J. 2013; 1: 41-60.
34. • Malkondu O, Kazandag MK, Kazazoglu E. A review on Biodentine, a contemporary dentine
replacement and repair material. 2014; 1-10.
• Natale LC, Rodrigues MC, Xavier TA, Simoes A, de Souza DN, Braga RR. Ion release and
mechanical properties of calcium silicate and calcium hydroxide materials used for pulp capping.
Int Endod J. 2015; 48(1):89-94.
• Nowicka A, Lipski M, Parafiniuk M, Sporniak-Tutak K, Lichota D, Kosierkiewicz A, Kaczmarek
W, Buczkowska-Radlinska J. Response of human dental pulp capped with biodentine and mineral
trioxide aggregate. J Endod. 2013; 39(6):743-747.
• Priyalakshmi S, Ranjan M. Review on Biodentine - A Bioactive dentine substitute. JDMS. 2014;
13(1): 13-17.
35. • Rajasekharan S, Martens LC, Cauwels RGEC, Verbeeck RMH. Biodentine™ material
characteristics and clinical applications: a review of the literature. Eur Arch Paediatr Dent. 2014;
15(3):147-158.
• Sans FA, Gomez-Rojas A, Jaureguizar GD. Biodentine™ as repair material for furcal perforation:
2 case reports. Septodont case studies collection. 2013; 5: 11-14.
• SEPTODONT. Biodentine™-Active Biosilicate technology™. 2013; 1-33. (www.septodont.com).
• SEPTODONT. Biodentine™ Brochure. 2013; 1-8. (www.septodont.com).
• Singh H, Kaur M, Markan S, Kapoor P. Biodentine: A promising dentin substitute. 2014; 2(5): 1-5.
• Tran XV, Gorin C, Willig C, Baroukh B, Pellat B, Decup F, Opsahl VS, Chaussain C, Boukpessi T.
Effect of a calcium-silicate-based restorative cement on pulp repair. J Dent Res. 2012; 91(12):1166-
1171.